Welcome, Guest. Please login or register.
November 20, 2019, 06:25:28 am

Login with username, password and session length


Members
Stats
  • Total Posts: 54561
  • Total Topics: 4660
  • Online Today: 58
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 52
Total: 52

Welcome

Welcome to the Hep Forums, a round-the-clock discussion area for people who have Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Triple-Target Hepatitis B Vaccine May Be More Effective  (Read 251 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 665
    • Hep Mag
Triple-Target Hepatitis B Vaccine May Be More Effective
« on: November 08, 2019, 11:15:22 am »
An experimental vaccine that contains three different hepatitis B virus (HBV) proteins may offer more protection—especially for older adults and people with a weaker immune system—than existing vaccines, according to study results presented at the recent IDWeek 2019 conference in Washington, DC.

Hepatitis B vaccination has led to a dramatic drop in new infections worldwide—a decrease that is expected to ultimately lead to a decline in cirrhosis, liver cancer and the need for liver transplants. Immunization is recommended for all infants starting soon after birth as well as for at-risk adults who were not vaccinated as children. These include people living with HIV, gay and bisexual men, people who inject drugs, people with chronic liver or kidney disease, those at risk for occupational HBV exposure and travelers to areas where the virus is more common.

Read more...
https://www.hepmag.com/article/tripletarget-hepatitis-b-vaccine-may-effective

 


© 2019 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.